(A Top Pick Nov 28/12. Up 9.9%.) 5.75% bond maturing August 31/18.
(Market Call Minute.) The negative on this is that they are big in Europe and the positive is that there is lots of consolidation in the industry.
5.75% bond maturing August 31/18. This is a convertible debenture. Company has fantastic interest coverage and very low debt.
Vitamin Business. Likes long term demographics of vitamin and supplement business. Unfortunately a lot of business is in Europe and is hurting them. Thinks there is definitely better places to be. He sold his holdings.
Atrium Innovations. is a OTC stock, trading under the symbol ATB-T on the (). It is usually referred to as or ATB-T
In the last year, there was no coverage of Atrium Innovations. published on Stockchase.
Atrium Innovations. was recommended as a Top Pick by on . Read the latest stock experts ratings for Atrium Innovations..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Atrium Innovations. In the last year. It is a trending stock that is worth watching.
On , Atrium Innovations. (ATB-T) stock closed at a price of $.
(Market Call Minute) Tender your shares. Gov’t may be reluctant to see this one go.